Innovations in Nanomedicine for Disease Management
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 40
Special Issue Editors
Interests: extravescicles; natural extracts; in-vitro and in-vivo assays
Interests: nanoparticles; biopolymers; bioavailability
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanomedicine represents a revolutionary frontier in disease management, leveraging the unique properties of nanoparticles to transform diagnostics, therapeutics and drug delivery systems. This Special Issue delves into cutting-edge advancements in nanotechnology that offer precise, targeted and efficient solutions for a broad spectrum of medical challenges. "Innovations in Nanomedicine for Disease Management" explores the applications of nanomedicine in early disease detection, personalized medicine and minimally invasive treatments. It covers breakthroughs in smart drug delivery systems, optimizing therapeutic outcomes while minimizing side effects. Additionally, this Special Issue highlights the integration of nanotechnology with emerging fields such as gene therapy, immunotherapy, and regenerative medicine, aiming to underscore the transformative potential of nanomedicine in enhancing patient care and revolutionizing contemporary healthcare practices. Researchers and practitioners are invited to contribute to these groundbreaking studies that pave the way for the next generation of disease management technologies.
Dr. Anna Valentino
Dr. Raffaele Conte
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- nanoparticles
- smart drug delivery
- personalized medicine
- minimally invasive treatments
- gene therapy
- regenerative medicine
